Showing results (31-40 of 295) with videos related to
Sort By:
Pageof 30
Journal of Neurodevelopmental Disorders|March 14, 2017
Erratum to: A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndromeMichelle Lee, Gary E Martin, Elizabeth Berry-Kravis, et al.Pediatric Neurology|May 18, 2023
Low Risk Profile of Long-Term Repeated Lumbar Puncture for Intrathecal Delivery of 2-Hydroxypropyl-Beta-Cyclodextrin in Patients With Niemann-Pick Type COrsolya K Albert, Katherine Friedmann, Rebecca Jaeger, et al.Journal of Geophysical Research. Atmospheres : JGR|April 19, 2021
Cloud Occurrences and Cloud Radiative Effects (CREs) from CCCM and CloudSat Radar-Lidar ProductsSeung-Hee Ham, Seiji Kato, Fred G Rose, et al.American Journal on Intellectual and Developmental Disabilities|November 19, 2020
Development of Neural Response to Novel Sounds in Fragile X Syndrome: Potential BiomarkersLauren Ethridge, Andrew Thaliath, Jeremy Kraff, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 24, 2019
Review of migraine incidence and management in obstetrics and gynaecologyVasilios Tanos, Elissa Abi Raad, Kelsey Elizabeth Berry, et al.American Journal on Intellectual and Developmental Disabilities|January 24, 2014
Feasibility, reproducibility, and clinical validity of the pediatric anxiety rating scale-revised for fragile X syndromeNicole M Russo-Ponsaran, Jessica Yesensky, David Hessl, et al.Journal of Autism and Developmental Disorders|January 27, 2011
Reliability of eye tracking and pupillometry measures in individuals with fragile X syndromeFaraz Farzin, Felicia Scaggs, Crystal Hervey, et al.Physics in Medicine and Biology|December 9, 2004
Materials for phantoms for terahertz pulsed imagingGillian C Walker, Elizabeth Berry, Stephen W Smye, et al.Neurobiology of Disease|March 28, 2024
Proteomics insights into fragile X syndrome: Unraveling molecular mechanisms and therapeutic avenuesDiana A Abbasi, Elizabeth Berry-Kravis, Xinyu Zhao, et al.Brain Sciences|December 20, 2018
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry PerspectiveAnna W Lee, Pamela Ventola, Dejan Budimirovic, et al.Pageof 30